SVA logo

Sinovac Biotech (SVA) Gross Margin

Annual Gross Margin

59.51%
+5.36%+9.90%

December 1, 2023

Summary

Performance

1-Year Change

+9.9%

3-Year Change

-31.47%

5-Year Change

-33.31%

15-Year Change

-32.67%

SVA Gross Margin Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

55.09%
SVA annual gross profit margin is higher than 55.09% of companies in Healthcare sector

High & Low

All-time High

94.47%
SVA annual gross profit margin is currently -37.01% below its historical high of 94.47%

3-Year Low

54.15%
SVA annual gross profit margin is currently +9.90% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 1, 2023
SVA previous annual earnings announcement was published on Dec 1, 2023

Next Annual Earnings Report Date

Aug 15, 2025
SVA next annual earnings announcement is scheduled for Aug 15, 2025

OtherSVAprofitabilitymetrics:

Annual Revenue

$448.27 M
SVA annual revenue is $448.27 million

Annual Gross Profit

$266.75 M
SVA annual gross profit is $266.75 million

Annual Operating Margin

-116.96%
SVA annual operating profit margin is -116.96%

Annual Net Margin

-22.29%
SVA annual net profit margin is -22.29%

Quarterly Gross Margin

N/A

June 1, 2024

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

SVA Quarterly Gross Margin Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

94.11%
SVA quarterly gross profit margin is currently at an all-time high

3-Year Low

-
SVA quarterly gross profit margin 3-year low is unknown

Earnings dates

Last Quarterly Earnings Report Date

Jun 1, 2024
SVA previous earnings announcement was published on Jun 1, 2024

Next Quarterly Earnings Report Date

Aug 15, 2025
SVA next earnings announcement is scheduled for Aug 15, 2025

OtherSVAprofitabilitymetrics:

Quarterly Revenue

-
SVA quarterly revenue value is unknown

Quarterly Gross Profit

-
SVA quarterly gross profit value is unknown

Quarterly Operating Margin

-
SVA quarterly operating profit margin value is unknown

Quarterly Net Margin

-
SVA quarterly net profit margin value is unknown

Gross Margin Formula

Gross Margin =  Gross Profit
Revenue ✕ 100%

Annual Gross Margin

59.51%
SVA annual gross profit margin is 59.51%

Annual Gross Profit

$266.75 M
SVA annual gross profit is $266.75 million

Annual Revenue

$448.27 M
SVA annual revenue is $448.27 million

SVA Gross Margin Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+9.9%-
3 y3 years-31.5%-
5 y5 years-33.3%-

SVA Gross Margin Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-37.0%+9.9%
5 y5-year-37.0%+9.9%
alltimeall time-37.0%+1166.5%

Sinovac Biotech Gross Margin History

DateAnnualQuarterly
Dec 2023
59.51%(+9.9%)
-
Dec 2022
54.15%(-42.7%)
-
Dec 2021
94.47%(+8.8%)
-
Dec 2020
86.84%(+0.0%)
86.71%(-1.2%)
Sep 2020
-
87.78%(+2.6%)
Jun 2020
-
85.55%(-1.8%)
Mar 2020
-
87.13%(+2.6%)
Dec 2019
86.80%(-2.7%)
84.90%(+1.2%)
Sep 2019
-
83.92%(-7.3%)
Jun 2019
-
90.49%(+0.9%)
Mar 2019
-
89.66%(+2.6%)
Dec 2018
89.23%(+1.0%)
87.35%(-4.4%)
Sep 2018
-
91.37%(+6.3%)
Jun 2018
-
85.97%(-8.6%)
Mar 2018
-
94.11%(+28.1%)
Dec 2017
88.39%(+28.0%)
-
Dec 2016
69.08%(-5.0%)
73.46%(-8.3%)
Sep 2016
-
80.15%(-146.8%)
Jun 2016
-
-171.39%(-396.7%)
Mar 2016
-
57.77%(-15.5%)
Dec 2015
72.69%(-3.6%)
68.33%(+2.1%)
Sep 2015
-
66.90%(-18.7%)
Jun 2015
-
82.25%(+9.8%)
Mar 2015
-
74.93%(-5.4%)
Dec 2014
75.41%(+5.6%)
79.22%(+11.7%)
Sep 2014
-
70.92%(-5.4%)
Jun 2014
-
74.98%(-1.1%)
Mar 2014
-
75.80%(+5.0%)
Dec 2013
71.43%(+16.7%)
72.16%(+9.1%)
Sep 2013
-
66.14%(-15.1%)
Jun 2013
-
77.88%(+10.9%)
Mar 2013
-
70.23%(+26.3%)
Dec 2012
61.19%
55.60%(+5.7%)
Sep 2012
-
52.61%(-38.3%)
DateAnnualQuarterly
Jun 2012
-
85.31%(+37.1%)
Mar 2012
-
62.24%(+0.4%)
Dec 2011
62.83%(+25.8%)
62.01%(+9.1%)
Sep 2011
-
56.83%(-17.4%)
Jun 2011
-
68.84%(+5.3%)
Mar 2011
-
65.40%(-416.9%)
Dec 2010
49.95%(-34.4%)
-20.64%(-130.2%)
Sep 2010
-
68.26%(-17.5%)
Jun 2010
-
82.70%(+3.2%)
Mar 2010
-
80.12%(+15.6%)
Dec 2009
76.17%(-3.1%)
69.28%(-16.2%)
Sep 2009
-
82.68%(+1.8%)
Jun 2009
-
81.20%(+4.2%)
Mar 2009
-
77.95%(+24.4%)
Dec 2008
78.63%(-2.5%)
62.66%(-22.7%)
Sep 2008
-
81.05%(-3.7%)
Jun 2008
-
84.18%(-4.5%)
Mar 2008
-
88.18%(+29.1%)
Dec 2007
80.61%(+11.3%)
68.32%(-19.3%)
Sep 2007
-
84.71%(-1.2%)
Jun 2007
-
85.70%(+7.2%)
Dec 2006
72.44%(-0.4%)
-
Jun 2006
-
79.91%(+10.0%)
Dec 2005
72.74%(+4.0%)
72.62%(0.0%)
Sep 2005
-
72.62%(-0.5%)
Jun 2005
-
73.02%(-4.2%)
Dec 2004
69.97%(+13.3%)
76.22%(+23.6%)
Sep 2004
-
61.68%(-7.6%)
Jun 2004
-
66.75%(-20.5%)
Dec 2003
61.75%(+35.1%)
83.97%(+206.7%)
Sep 2003
-
27.38%
Apr 2002
45.69%(+44.5%)
-
Apr 2001
31.62%(-666.7%)
-
Apr 2000
-5.58%
-

FAQ

  • What is Sinovac Biotech annual gross profit margin?
  • What is the all time high annual gross margin for Sinovac Biotech?
  • What is Sinovac Biotech annual gross margin year-on-year change?
  • What is the all time high quarterly gross margin for Sinovac Biotech?

What is Sinovac Biotech annual gross profit margin?

The current annual gross margin of SVA is 59.51%

What is the all time high annual gross margin for Sinovac Biotech?

Sinovac Biotech all-time high annual gross profit margin is 94.47%

What is Sinovac Biotech annual gross margin year-on-year change?

Over the past year, SVA annual gross profit margin has changed by +5.36% (+9.90%)

What is the all time high quarterly gross margin for Sinovac Biotech?

Sinovac Biotech all-time high quarterly gross profit margin is 94.11%